FDA OKs Talquetamab, a First-in-Class Multiple Myeloma Drug.

Published Date: 12 Aug 2023

The FDA's approval comes after a number of other multiple myeloma medications that had previously received accelerated FDA approval were taken off the market.

Read Full News

Latest News



Latest News

HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503HTTP error: 503 HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503 HTTP error: 503HTTP error: 503HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot